The Latin America, Middle East and Africa Cat Vaccine Market would witness market growth of 11.7% CAGR during the forecast period (2024-2031).
The Brazil market dominated the LAMEA Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $54 million by 2031. The Argentina market is capturing a CAGR of 12.6% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 10.9% during (2024 - 2031).
The development of recombinant DNA technology has enabled the production of vaccines that can target specific pathogens with greater precision. This method reduces the risk of adverse reactions and enhances the immune response in cats. As a result, newer vaccines can offer longer-lasting protection against diseases such as feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), and rabies, contributing to cats' overall health and longevity.
Despite the positive trends, the market also faces several challenges. One of the most significant barriers is the high cost of vaccines, which can deter pet owners, especially those with multiple cats or limited financial resources. Even with the availability of pet insurance, the upfront costs associated with comprehensive vaccination schedules can be prohibitive for some. This financial burden can lower vaccination rates, leaving cats vulnerable to preventable diseases.
The South African Veterinary Association (SAVA) has actively promoted the importance of regular vaccinations through public health initiatives and educational campaigns. The Department of Agriculture, Forestry, and Fisheries (DAFF) supports these efforts by ensuring that veterinary services are accessible and affordable. The demand for cat vaccines has been driven by enhanced public awareness and the increasing disposable income of pet owners, who are more inclined to invest in preventive healthcare for their animals. Thus, the LAMEA cat vaccine market has growth potential fueled by rising pet ownership and increasing awareness of animal welfare.
Free Valuable Insights: The Worldwide Cat Vaccine Market is Projected to reach USD 2.5 Billion by 2031, at a CAGR of 9.2%
Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
By Component
By Route of Administration
By Duration of Immunity
By Disease Type
By Type
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 